Nuvalent, Inc. 4

Nuvalent, Inc. President and CEO James Richard Porter exercised 30,000 stock options and sold 30,000 shares of Class A Common Stock for about $3.7 million on July 6, 2026 under a Rule 10b5-1 plan.

On July 6, 2026, Nuvalent, Inc. President and CEO James Richard Porter exercised stock options for 30,000 shares of Class A Common Stock at an exercise price of $18.93 per share and immediately sold the same 30,000 shares at a weighted average price of $123.72 per share pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025. The option exercise itself is a non-cash event (reported at $0.00 in the derivative transaction table), while the gross value of the sale is approximately $3.7 million, with an implied intrinsic gain of roughly $3.1 million based on the exercise price. Following these transactions, Porter’s direct ownership decreased from 354,879 to 324,879 shares of Class A Common Stock, and he also continues to hold 118,686 shares underlying fully vested stock options expiring January 4, 2032.

Filing Facts

CIK

1861560

Ticker

NUVL

Form

4

Source Type

fda

Accession

0001862900-26-000011

Alert Tier

6